Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2022 October;74(5) > Minerva Urology and Nephrology 2022 October;74(5):638-40

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Minerva Urology and Nephrology 2022 October;74(5):638-40

DOI: 10.23736/S2724-6051.22.04886-8

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

Perioperative outcomes after radical prostatectomy: does the surgical approach change the impact of hospital volume? A nationwide analysis

Michael BABOUDJIAN 1, 2, 3 , Bastien GONDRAN-TELLIER 1, Annabelle GRABIA 4, Eric BARRET 5, Jean-Baptiste BEAUVAL 3, Laurent BRUREAU 6, Gilles CREHANGE 7, Charles DARIANE 8, Gaëlle FIARD 9, Gaëlle FROMONT 10, Mathieu GAUTHE 11, Romain MATHIEU 12, Raphaële RENARD-PENNA 13, Guilhem ROUBAUD 14, Alain RUFFION 15, 16, Paul SARGOS 17, Charles-Edouard LEQUEU 4, Morgan ROUPRET 18, Guillaume PLOUSSARD 3

1 Department of Urology and Kidney Transplantation, APHM, Conception Academic Hospital, Marseille, France; 2 Department of Urology, APHM, North Academic Hospital, Marseille, France; 3 Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France; 4 Department of Public Health, PMSI, Ramsay Santé, France; 5 Department of Urology, Institut Mutualiste Montsouris, Paris, France; 6 Department of Urology, CHU de Pointe-à-Pitre, University of Antilles, University of Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail), Pointe-à-Pitre, France; 7 Department of Radiotherapy, Curie Institute, Paris, France; 8 Department of Urology, Georges-Pompidou European Hospital, University of Paris, Paris, France; 9 Department of Urology, Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France; 10 Department of Pathology, CHRU Tours, Tours, France; 11 Department of Nuclear Medicine, Scintep - Institut Daniel Hollard, Grenoble, France; 12 Department of Urology, CHU Rennes, Rennes, France; 13 Department of Radiology, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France; 14 Department of Medical Oncology, Bergonié Institute, Bordeaux, France; 15 Department of Urology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France; 16 Equipe 2 - Centre d’Innovation en Cancérologie de Lyon (EA 3738 CICLY), Faculty of Medicine Lyon Sud, University Lyon1, Lyon, France; 17 Department of Radiotherapy, Bergonié Institute, Bordeaux, France; 18 Department of Urology, GRC 5 Predictive Onco-Uro, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France



inizio pagina